ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.

about

ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.

Item

http://www.wikidata.org/entity/Q41721741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

ERCC1_202 Is A Prognostic Biom ...... h Platinum-Based Chemotherapy.

@en

type

Item

label

ERCC1_202 Is A Prognostic Biom ...... h Platinum-Based Chemotherapy.

@en

prefLabel

ERCC1_202 Is A Prognostic Biom ...... h Platinum-Based Chemotherapy.

@en

P1476

ERCC1_202 Is A Prognostic Biom ...... h Platinum-Based Chemotherapy.

@en

P2093

Chenbo Ding

http://www.w3.org/2001/XMLSchema#string

Guoqiu Wu

http://www.w3.org/2001/XMLSchema#string

Hongming Zhang

http://www.w3.org/2001/XMLSchema#string

Jianwen Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaobo Fan

http://www.w3.org/2001/XMLSchema#string

Xiaoli Zhu

http://www.w3.org/2001/XMLSchema#string

Xiulei Xue

http://www.w3.org/2001/XMLSchema#string

Xiyong Wang

http://www.w3.org/2001/XMLSchema#string

Yan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China

Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancer

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

ERCC1 and BRCA1 mRNA expression predicts the clinical outcome of non-small cell lung cancer receiving platinum-based chemotherapy.

ERCC1 Expression Analysis to Guide Therapy in Non-Small Cell Lung Cancer.

Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform

Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study.

P304

2846-2853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.19897

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28928874

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5604217

http://www.w3.org/2001/XMLSchema#string